Reporte zur Charge EWU161

Symptomtext

Could not see; Blurred vision in the left eye; This is a spontaneous report from a contactable consumer (patient). A 53-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 15Apr2021 at 16:15 (Batch/Lot Number: EWU161) as DOSE 2, SINGLE for COVID-19 immunization. Medical history was reported as none. The patient did not have any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ibuprofen (ADVIL) taken for an unspecified indication, start and stop date were not reported. The patient did not receive other vaccinations within four weeks prior to COVID vaccine. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 in the left arm on 25Mar2021 at 16:00 (Batch/Lot Number: ER8727) as DOSE 1, SINGLE for COVID-19 immunization. On 16Apr2021 at 04:30, the patient experienced blurred vision in the left eye; woke up 13 hours after the shot and had foggy vision but not bad; got worse throughout the day; by 24 hours after the shot, complete white out in left eye; could not see. The patient did not receive any treatment for the events. The clinical outcome of the blindness and vision blurred was recovered on 17Apr2021 (by 27 hours started to see improvement; woke up 37 hours after shot with vision back). It was reported that since the vaccination, the patient had not been tested for COVID-19.